Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy
The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia.
Hologic Obtains CE Mark for AI-Based Cervical Cancer Screening Platform
Hologic designed its scalable AI-based cytology platform to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women.
FDA Approves Expanded Use for Roche Cytology Test in Patients With Cervical Cancer
The test detects the presence of two biomarkers within a single cell associated with HPV infections that can progress to cervical cancer.
BD Receives FDA Supplemental Premarket Approval for Extended Genotyping HPV MDx
The expanded test can be used for genotype risk-based patient monitoring to prevent over-treatment, BD has said.
NCI Researchers Leverage Machine Learning for Accurate, Broader-Scale Cervical Cancer Screening
The researchers are developing an automated machine-learning approach to analyze the expression of protein markers associated with cervical cancer.